NO20004316L - Meta azacyclic aminobenzoic acid compounds and derivatives thereof which are integrin antagonists - Google Patents

Meta azacyclic aminobenzoic acid compounds and derivatives thereof which are integrin antagonists

Info

Publication number
NO20004316L
NO20004316L NO20004316A NO20004316A NO20004316L NO 20004316 L NO20004316 L NO 20004316L NO 20004316 A NO20004316 A NO 20004316A NO 20004316 A NO20004316 A NO 20004316A NO 20004316 L NO20004316 L NO 20004316L
Authority
NO
Norway
Prior art keywords
meta
derivatives
acid compounds
aminobenzoic acid
integrin antagonists
Prior art date
Application number
NO20004316A
Other languages
Norwegian (no)
Other versions
NO20004316D0 (en
NO315703B1 (en
Inventor
Thomas E Rogers
Peter G Ruminski
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO20004316D0 publication Critical patent/NO20004316D0/en
Publication of NO20004316L publication Critical patent/NO20004316L/en
Publication of NO315703B1 publication Critical patent/NO315703B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20004316A 1998-03-04 2000-08-30 Meta azacyclic aminobenzoic acid compounds and derivatives thereof which are integrin antagonists NO315703B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3427098A 1998-03-04 1998-03-04
PCT/US1999/003281 WO1999044994A1 (en) 1998-03-04 1999-02-22 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists

Publications (3)

Publication Number Publication Date
NO20004316D0 NO20004316D0 (en) 2000-08-30
NO20004316L true NO20004316L (en) 2000-11-06
NO315703B1 NO315703B1 (en) 2003-10-13

Family

ID=21875345

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004316A NO315703B1 (en) 1998-03-04 2000-08-30 Meta azacyclic aminobenzoic acid compounds and derivatives thereof which are integrin antagonists

Country Status (29)

Country Link
EP (1) EP1060164A1 (en)
JP (1) JP2002505323A (en)
KR (1) KR20010041584A (en)
CN (1) CN1214011C (en)
AP (1) AP1244A (en)
AR (1) AR018139A1 (en)
AU (1) AU753230B2 (en)
BG (1) BG104740A (en)
BR (1) BR9908470A (en)
CA (1) CA2322207A1 (en)
EA (1) EA200000804A1 (en)
EE (1) EE200000506A (en)
GE (1) GEP20033118B (en)
HR (1) HRP20000574A2 (en)
HU (1) HUP0100865A3 (en)
ID (1) ID25591A (en)
IL (1) IL137653A0 (en)
IS (1) IS5582A (en)
MY (1) MY123908A (en)
NO (1) NO315703B1 (en)
NZ (1) NZ506598A (en)
OA (1) OA11530A (en)
PL (1) PL342726A1 (en)
SK (1) SK13002000A3 (en)
TR (1) TR200002542T2 (en)
UA (1) UA71906C2 (en)
WO (1) WO1999044994A1 (en)
YU (1) YU52000A (en)
ZA (1) ZA994406B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
DE60130910T2 (en) 2000-04-17 2008-07-10 Ucb Pharma, S.A. ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6921767B2 (en) * 2000-06-15 2005-07-26 Pharmacia Corporation Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
AU2001275724A1 (en) 2000-08-02 2002-02-13 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
JP2006514050A (en) * 2002-12-20 2006-04-27 ファルマシア・コーポレーション R isomers of β-amino acid compounds as integrin receptor antagonist derivatives
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
CN101233121A (en) * 2005-06-10 2008-07-30 彼帕科学公司 PARP Modulators and Cancer Therapy
JP2010520238A (en) 2007-03-01 2010-06-10 マリンクロット インコーポレイテッド Integrated photoactive small molecule and integrated photoactive small molecule use
JP4792124B1 (en) * 2010-11-15 2011-10-12 エフイートレード株式会社 Method for molding protective film for vehicle and method for manufacturing protective film for vehicle
WO2014015054A1 (en) 2012-07-18 2014-01-23 Saint Louis University Beta amino acid derivatives as integrin antagonists
US8716226B2 (en) 2012-07-18 2014-05-06 Saint Louis University 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
ES2864079T3 (en) 2014-05-30 2021-10-13 Pfizer Carbonitrile derivatives as selective androgen receptor modulators
BR112016028370B1 (en) * 2014-06-04 2021-03-09 Monsanto Technology Llc process for the preparation of 3,6-dichlorosalicylic acid compounds
SG11201805387RA (en) 2015-12-30 2018-07-30 Univ Saint Louis Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
KR20230011967A (en) 2020-05-14 2023-01-25 유비이 가부시키가이샤 1,4,5,6-tetrahydropyrimidin-2-amine derivatives
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
WO2023085396A1 (en) 2021-11-12 2023-05-19 Ube株式会社 Pharmaceutical composition for providing treatment for or preventing alport syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123164A (en) * 1995-08-30 2001-03-19 Searle & Co Meta-guanidine urea thiourea or azacyclic amino benzoic acid derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GEP20033118B (en) 2003-11-25
HRP20000574A2 (en) 2001-08-31
EE200000506A (en) 2002-04-15
AP1244A (en) 2004-02-04
CA2322207A1 (en) 1999-09-10
HUP0100865A2 (en) 2001-08-28
CN1291978A (en) 2001-04-18
AP2000001893A0 (en) 2000-09-30
HUP0100865A3 (en) 2001-11-28
ID25591A (en) 2000-10-19
OA11530A (en) 2004-05-17
NO20004316D0 (en) 2000-08-30
SK13002000A3 (en) 2001-07-10
PL342726A1 (en) 2001-07-02
IS5582A (en) 2000-08-04
EP1060164A1 (en) 2000-12-20
CN1214011C (en) 2005-08-10
ZA994406B (en) 2000-02-11
WO1999044994A1 (en) 1999-09-10
JP2002505323A (en) 2002-02-19
TR200002542T2 (en) 2001-05-21
NZ506598A (en) 2003-07-25
EA200000804A1 (en) 2001-04-23
YU52000A (en) 2003-02-28
BR9908470A (en) 2000-12-05
AU3294799A (en) 1999-09-20
KR20010041584A (en) 2001-05-25
AR018139A1 (en) 2001-10-31
MY123908A (en) 2006-06-30
BG104740A (en) 2001-02-28
AU753230B2 (en) 2002-10-10
IL137653A0 (en) 2001-10-31
UA71906C2 (en) 2005-01-17
NO315703B1 (en) 2003-10-13

Similar Documents

Publication Publication Date Title
NO20004316L (en) Meta azacyclic aminobenzoic acid compounds and derivatives thereof which are integrin antagonists
DE69829086D1 (en) Vial for implant
ATE358670T1 (en) AROMATIC NITROGEN-CONTAINING SIX-RING COMPOUNDS
DK1089726T3 (en) A composition comprising beta-hydroxy-beta-methylbutyric acid and at least one amino acid
ID27415A (en) PHARMACEUTICAL COMPOSITION
DE19983276T1 (en) Solid state transformer
NO20020307L (en) N- (indolecarbonyl) -piperazine
DK0970955T3 (en) Paroxetine methanesulfonate
ID29089A (en) MOKSIFLOXASIN PHARMACEUTICAL PROPERTIES
DE69941416D1 (en) calibrate information
NO994626L (en) Substituted benzamides
ID27201A (en) PHARMACEUTICAL COMPOSITION
DE60038322D1 (en) recorder
ID26665A (en) VLA-4 ANTAGONISTS
DE69932639D1 (en) DATA INTEGRITY MONITORING
DK1056448T3 (en) Pharmaceutical combinations with tramadol
ID27150A (en) PHARMACEUTICAL MATERIALS LEVOTIROXIDE
PL364757A1 (en) Compound screening test
ATE252547T1 (en) MATRIXMETALLOPROTEINASE INHIBITORS
NO20010165D0 (en) polyisocyanate
ID27605A (en) TERNAL RECORDER MATERIALS
DE60032034D1 (en) recorder
NO20015237D0 (en) Integrin antagonists
NO990717D0 (en) Monitor st ° ttemekanisme
DE50003014D1 (en) N-SUBSTITUTED PERHYDRODIAZINE

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees